Use of NMR Metabolomics To Analyze the Targets of d-Cycloserine in Mycobacteria: Role of d-Alanine Racemase
Authors:
- 3 November 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (12) , 4608-4614
Abstract
D-Cycloserine (DCS) is only used with multidrug-resistant strains of tuberculosis because of serious side effects. DCS is known to inhibit cell wall biosynthesis, but the in vivo lethal target is still unknown. We have applied NMR-based metabolomics combined with principal component analysis to monitor the in vivo effect of DCS on Mycobacterium smegmatis. Our analysis suggests DCS functions by inhibiting multiple protein targets.Keywords
This publication has 46 references indexed in Scilit:
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- NMR Metabolic Profiling of Aspergillus nidulans to Monitor Drug and Protein ActivityJournal of Proteome Research, 2006
- Bacterial Cell Wall Synthesis: New Insights from Localization StudiesMicrobiology and Molecular Biology Reviews, 2005
- N Glycolylation of the Nucleotide Precursors of Peptidoglycan Biosynthesis of Mycobacterium spp. Is Altered by Drug TreatmentJournal of Bacteriology, 2005
- Self-protection Mechanism in d-Cycloserine-producing Streptomyces lavendulaeJournal of Biological Chemistry, 2004
- Metabolomics and systems biology: making sense of the soupCurrent Opinion in Microbiology, 2004
- Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDSScience, 2003
- Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networksComparative and Functional Genomics, 2001
- Multidrug-Resistant Mycobacterium tuberculosis: Molecular PerspectivesEmerging Infectious Diseases, 1998
- A relational database for sequence-specific protein NMR dataJournal of Biomolecular NMR, 1991